Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens

Psychopharmacology

Volumn 233, Issue 5, 2016, Pages 831-840

  Fu, Kequan ^a   Lin, Huiyang ^a,b   Miyamoto, Yoshiaki ^a   Wu, Chunfu ^b   Yang, Jingyu ^b   Uno, Kyosuke ^a   Nitta, Atsumi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Dopamine; GABA; Methamphetamine; Microdialysis; Nucleus accumbens; Pseudoginsenoside F11; opioid receptors

Indexed keywords

4 AMINOBUTYRIC ACID; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; METHAMPHETAMINE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PSEUDOGINSENOSIDE F11; SAPONIN; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; GINSENOSIDE; NARCOTIC ANALGESIC AGENT;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG ANTAGONISM; DRUG STRUCTURE; EXPERIMENTAL HYPERACTIVITY; GABAERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METHAMPHETAMINE DEPENDENCE; MICRODIALYSIS; MICROINJECTION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PANAX QUINQUEFOLIUS; PLACE PREFERENCE; PRIORITY JOURNAL; STEREOTYPY; WITHDRAWAL SYNDROME; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; INSTRUMENTAL CONDITIONING; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOPAMINERGIC NEURONS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GAMMA-AMINOBUTYRIC ACID; GINSENOSIDES; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; NEURONS; NUCLEUS ACCUMBENS; RECEPTORS, OPIOID, MU;

EID: 84958101816     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-015-4159-8     Document Type: Article

References (44)

1. Besso H, Kasai R, Wei J, Eang JF, Saruwatari YI, Fuwa T, Tanaka O (1982) Further studies on dammarane-saponins of American ginseng, roots of Panax quinquefolium L. Chem Pharm Bull 30:4534-4538
2. Bocklisch C, Pascoli V, Wong JC, House DR, Yvon C, de Roo M, Tan KR, Lüscher C (2013) Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area. Science 341:1521-1525
3. Chien CC, Lee YJ, Fan LW, Ho IK, Tien LT (2012) Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice. Toxicol Lett 212:61-65
4. Chiu CT, Ma T, Ho IK (2005) Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone. Brain Res Bull 67:100-109
5. Contet C, Kieffer BL, Befort K (2004) Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 14:370-378
6. Devine DP, Leone P, Pocock D, Wise RA (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266:1236-1246
7. Dewey SL, Smith GS, Logan J, Brodie JD, Yu DW, Ferrieri RA, King PT, MacGregor RR, Martin TP, Wolf AP (1992) GABAergic inhibition of endogenous dopamine release measured in vivo with 11C-raclopride and positron emission tomography. J Neurosci 12:3773-3780
8. Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dor-sal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067-1080
9. Feigenbaum JJ, Howard SG (1997) Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study. Life Sci 60:1659-1668
10. Ferraro L, Tanganelli S, O'Connor WT, Antonelli T, Rambert F, Fuxe K (1996) The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol 306:33-39
11. Furukawa-Hibi Y, Nitta A, Fukumitsu H, Somiya H, Furukawa S, Nabeshima T, Yamada K (2010) Overexpression of piccolo C2A domain induces depression-like behavior in mice. Neuroreport 21:1177-1181
12. Grant KM, LeVan TD, Wells SM, Li M, Stoltenberg SF, Gendelman HE, Carlo G, Bevins RA (2012) Methamphetamine-associated psychosis. J Neuroimmune Pharmacol 7:113-139
13. Hipólito L, Sánchez-Catalán MJ, Zanolini I, Polache A, Granero L (2008) Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens. Neuropharmacology 55:183-189
14. Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N (2005) Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 135:213-225
15. Iversen SD, Kelly PH, Miller RJ, Seviour P (1975) Proceedings: amphetamine and apomorphine responses in the rat after lesion of mesolimbic or striatal dopamine neurones. Br J Pharmacol 54:244P
16. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483-488
17. Katsuura Y, Taha SA (2010) Modulation of feeding and locomotion through mu and delta opioid receptor signaling in the nucleus accumbens. Neuropeptides 44:225-232
18. B receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. J Pharmacol Exp Ther 308:667-678
19. Li Z, Guo YY, Wu CF, Li X, Wang JH (1999) Protective effects of pseudoginsenoside-F11 on scopolamine-induced memory impairment in mice and rats. J Pharm Pharmacol 51:435-440
20. Li Z, Wu CF, Pei G, Guo YY, Li X (2000) Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice. Pharmacol Biochem Behav 66:595-601
21. Li Z, Xu NJ, Wu CF, Xiong Y, Fan HP, Zhang WB, Sun Y, Pei G (2001) Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary-mu cells. Neuroreport 12:1453-1456
22. Li L, Luo GA, Liang QL, Hu P, Wang YM (2010) Rapid qualitative and quantitative analyses of Asian ginseng in adulterated American ginseng preparations by UPLC/Q-TOF-MS. J Pharm Biomed Anal 52:66-72
23. Marshall JF, O'Dell SJ (2012) Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci 35:536-545
24. Matthews RT, German DC (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience 11:617-625
25. Miyamoto Y, Yamada K, Nagai T, Mori H, Mishina M, Furukawa H, Noda Y, Nabeshima T (2004) Behavioural adaptations to addictive drugs in mice lacking the NMDA receptor epsilon1 subunit. Eur J Neurosci 19:151-158
26. Niwa M, Nitta A, Mizoguchi H, Ito Y, Noda Y, Nagai T, Nabeshima T (2007a) A novel molecule "Shati" is involved in methamphetamine-induced hyperlocomotion, sensitization, and conditioned place preference. J Neurosci 27:7604-7615
27. Niwa M, Nitta A, Yamada Y, Nakajima A, Saito K, Seishima M, Shen L, Noda Y, Furukawa S, Nabeshima T (2007b) An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization. Biol Psychiatry 61:890-901
28. Okutsu H, Watanabe S, Takahashi I, Aono Y, Saigusa T, Koshikawa N, Cools AR (2006) Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively. Neuropsychopharmacology 31:375-383
29. Parker KE, McCall JG, McGuirk SR, Trivedi S, Miller DK, Will MJ (2015) Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective μ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat. Brain Res 1618:309-315
30. Pijnenburg AJ, Honig WM, Van der Heyden JA, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45-58
31. Rahman S, McBride WJ (2002) Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area. J Neurochem 80:646-654
32. Sabol KE, Roach JT, Broom SL, Ferreira C, Preau MM (2001) Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo. Brain Res 892:122-129
33. Schad CA, Justice JB, Holtzman SG (1996) Differential effects of δ- and μ-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem 67:2292-2299
34. Schad CA, Justice JB, Holtzman SG (2002) Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions. J Pharmacol Exp Ther 300:932-938
35. Shen X, Purser C, Tien LT, Chiu CT, Paul IA, Baker R, Loh HH, Ho IK, Ma T (2010) mu-opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization. J Neurosci Res 88:2294-2302
36. Svingos AL, Moriwaki A, Wang JB, Uhl GR, Pickel VM (1997) μ-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J Neurosci 17:2585-2594
37. Trujillo KA, Smith ML, Guaderrama MM (2011) Powerful behavioral interactions between methamphetamine and morphine. Pharmacol Biochem Behav 99:451-458
38. Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390:4
39. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F (2011) Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A 108:15037-15042
40. Wang CM, Liu MY, Wang F, Wei MJ, Wang S, Wu CF, Yang JY (2013) Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease. Pharmacol Biochem Behav 106:57-67
41. Warner-Schmidt JL, Schmidt EF, Marshall JJ, Rubin AJ, Arango-Lievano M, Kaplitt MG, Ibañez-Tallon I, Heintz N, Greengard P (2012) Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci U S A 109:11360-11365
42. Wu CF, Liu YL, Song M, Liu W, Wang JH, Li X, Yang JY (2003) Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice. Pharmacol Biochem Behav 76:103-109
43. Yan Q (1999) Focal bicuculline increases extracellular dopamine concentration in the nucleus accumbens of freely moving rats as measured by in vivo microdialysis. Eur J Pharmacol 385:7-13
44. Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386:499-502